Newtyn Management, LLC Theravance Biopharma, Inc. Put Options Transaction History
Newtyn Management, LLC
- $507 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TBPH
# of Institutions
134Shares Held
46.9MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$86.9 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$68.2 Million1.9% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$34.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.2 Million3.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$19 Million0.0% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $610M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...